SWK (SWKH) Expected to Announce Quarterly Earnings on Monday

SWK (NASDAQ:SWKH) is expected to post its Q4 2025 resultson Monday, April 6th. Analysts expect the company to announce earnings of $0.5250 per share for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 26, 2026 at 10:00 AM ET.

SWK Stock Performance

NASDAQ SWKH opened at $17.10 on Monday. SWK has a 1-year low of $13.17 and a 1-year high of $20.49. The company has a 50 day moving average of $17.01 and a 200-day moving average of $16.57. The company has a current ratio of 9.41, a quick ratio of 9.41 and a debt-to-equity ratio of 0.14. The firm has a market cap of $206.91 million, a price-to-earnings ratio of 9.19 and a beta of 0.30.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “hold (c)” rating on shares of SWK in a research report on Monday, December 29th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $18.00.

Institutional Investors Weigh In On SWK

A number of institutional investors and hedge funds have recently made changes to their positions in SWKH. Raymond James Financial Inc. lifted its stake in shares of SWK by 297.5% during the second quarter. Raymond James Financial Inc. now owns 74,657 shares of the company’s stock valued at $1,100,000 after acquiring an additional 55,874 shares during the period. Goldman Sachs Group Inc. increased its position in SWK by 142.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 38,400 shares of the company’s stock worth $660,000 after purchasing an additional 22,546 shares during the period. NewEdge Advisors LLC increased its position in SWK by 5,440.8% in the third quarter. NewEdge Advisors LLC now owns 17,509 shares of the company’s stock worth $255,000 after purchasing an additional 17,193 shares during the period. AQR Capital Management LLC raised its holdings in SWK by 31.8% during the 4th quarter. AQR Capital Management LLC now owns 25,603 shares of the company’s stock worth $440,000 after purchasing an additional 6,183 shares during the last quarter. Finally, Bridgeway Capital Management LLC raised its holdings in SWK by 2.9% during the 2nd quarter. Bridgeway Capital Management LLC now owns 114,277 shares of the company’s stock worth $1,684,000 after purchasing an additional 3,263 shares during the last quarter. Institutional investors own 99.27% of the company’s stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.